SNY
Sanofi$41.33
+0.09%LiveJun 24, 2026
Market cap
$99.37B
52w range
40.89 – 52.68
P / E
—
EPS
—
Volume
7.35M
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Sanofi’s valuationNext report
upcomingNo forward estimate on file.
Beat streak
0
consecutive EPS beats
Avg surprise
—
trailing 0q
EPS · actual vs estimate
· earnings_historyactualestimate
No earnings history on file.
Forward consensus
No forward annual estimates on file.
Revenue · actual vs estimate ($B)
No revenue estimate history on file.
Reports tracked
0
Beat rate
—
0 beats · 0 misses (last 12)
Next report
—
Last report
—
Earnings call transcripts
DB24| Period | Date | Words | Excerpt | |
|---|---|---|---|---|
| FY2025 Q4 | Jan 29, 2026 | 9,476 | Thomas Larsen: Hello, everyone, this Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q4 and Full Year 2025 Conference Call for investors and analysts. As usual, you can find slides on sano | Read → |
| FY2025 Q3 | Oct 24, 2025 | 9,723 | Thomas Larsen: Hello everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q3 2025 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. | Read → |
| FY2025 Q2 | Jul 31, 2025 | 10,336 | Thomas Kudsk Larsen: Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q2 2025 conference call for investors and analysts. As usual, you can find the slides on sanof | Read → |
| FY2025 Q1 | Apr 24, 2025 | 10,421 | Thomas Guslatin: Hello, everyone. This is Thomas Guslatin from the Sanofi IR team. Welcome to the Q1 2025 Conference Call for investors and analysts. As usual, you can find the slides on sanofi.com. P | Read → |
| FY2024 Q4 | Jan 30, 2025 | 11,497 | Thomas Larsen: Welcome to the Q4 and Full Year 2024 Conference Call for Investors and Analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide number 3. Here we have the usual f | Read → |
| FY2024 Q3 | Oct 25, 2024 | 11,477 | Thomas Kudsk: Welcome to the Q3 2024 Conference Call for Investors and Analysts. As usual, you can find the slides on sanofi.com. Please turn to slide number three. Here we have the usual forward-look | Read → |
| FY2024 Q2 | Jul 25, 2024 | 9,393 | Thomas Kudsk: This is Thomas Kudsk Larsen with the IR team. Welcome to the Q2 2024 Conference Call for investors and analyst. As usual, you can find the slides on sanofi.com. Please turn to slide 3. H | Read → |
| FY2024 Q1 | Apr 25, 2024 | 12,457 | Paul Hudson: Welcome to the Q1 2024 conference call. You can find the slides of this call on the sanofi.com Investors Page. I'd like to remind you that the information presented in this call contains | Read → |
| FY2023 Q4 | Feb 01, 2024 | 9,922 | Eva Schaefer-Jansen: Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's Fourth Quarter and Full Year 2023 Results, followed by a Q&A session. As usu | Read → |
| FY2023 Q3 | Oct 27, 2023 | 11,684 | Eva Schaefer-Jansen: [starts abruptly] You have joined the meeting as an attendee and will be muted throughout the meeting. This meeting is being recorded. 2023 results followed by a Q&A session. As u | Read → |
| FY2023 Q2 | Jul 28, 2023 | 12,135 | Eva Schaefer-Jansen: Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's Second Quarter 2023 Results followed by Q&A session. As usual, you can find | Read → |
| FY2023 Q1 | Apr 27, 2023 | 13,487 | Eva Schaefer-Jansen: Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's first quarter 2023 results followed by a Q&A session. As usual, you can find | Read → |
| FY2022 Q4 | Feb 03, 2023 | 12,371 | Eva Schaefer-Jansen: [Call Starts Abruptly] find the slides to this earnings call on the Investors page of our website at sanofi.com. Moving to slide 3, I would like to remind you that information pre | Read → |
| FY2022 Q3 | Oct 28, 2022 | 12,475 | Eva Schaefer-Jansen: Good morning, good afternoon, and good evening to everyone. Thank you for joining us to review Sanofi’s 2022 third quarter results, followed by a Q&A session. As usual, you can fi | Read → |
| FY2022 Q2 | Jul 28, 2022 | 12,431 | Eva Schaefer-Jansen: Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's 2022 Second Quarter Results followed by a Q&A session. As usual, you can fin | Read → |
| FY2022 Q1 | Apr 28, 2022 | 12,492 | Eva Schaefer-Jansen: Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's 2022 first quarter results followed by a Q&A session. As usual, you can find | Read → |
| FY2021 Q4 | Feb 04, 2022 | 13,560 | Eva Schaefer-Jansen: Good morning, good afternoon, and good evening to everyone. Thank you for joining us to review Sanofi’s 2021 Fourth Quarter and Full Year Results followed by a Q&A session. As usu | Read → |
| FY2021 Q3 | Oct 28, 2021 | 13,035 | Operator: Welcome to the Sanofi's Third Quarter 2021 earnings call. I would now like to turn the call over to Eva Schaefer-Jansen, Head of Sanofi Investor Relations. Please go-ahead Eva. Eva Schaefer | Read → |
| FY2021 Q2 | Jul 29, 2021 | 12,798 | Eva Schaefer-Jansen: [Technical Difficulty] followed by a Q&A session. As usual, you can find the slides to this earnings call on the Investors page of our website at sanofi.com. Moving to Slide 2. I | Read → |
| FY2021 Q1 | Apr 29, 2021 | 8,853 | Operator: [Starts Abruptly] Sanofi's First Quarter 2021 Earnings Call. I would now like to turn the call over to Eva Schaefer-Jansen, Head of Sanofi Investor Relations. Please go ahead, Eva. Eva Schae | Read → |
| FY2020 Q4 | Feb 05, 2021 | 27,078 | Operator: This meeting is being recorded. Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi Fourth Quarter 2020 Earnings Call and Virtual Capital Markets Day. We have planned for | Read → |
| FY2020 Q3 | Oct 29, 2020 | 14,572 | Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi Investor Call on the Q3 2020 earnings. I would now like to turn the call over to Eva Schaefer-Jansen from Sanofi Invest | Read → |
| FY2020 Q2 | Jul 29, 2020 | 12,560 | Operator: Ladies and gentlemen, thank you for standing by. Welcome to Sanofi’s investor call on the Q2 2020 earnings. I would now like to turn the call over to Eva Schaefer-Jansen from Sanofi Investor | Read → |
| FY2020 Q1 | Apr 24, 2020 | 13,702 | Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi's First Quarter 2020 Earnings Conference Call. I would now like to turn the call over to Felix Lauscher, from Sanofi In | Read → |
Click Read → for the full transcript with keyword cloud and on-demand AI analyst summary.
Earnings surprises · history
DB · earnings_surprises100% beat2| Period end | Estimate EPS | Actual EPS | Surprise % | Outcome |
|---|---|---|---|---|
| Apr 23, 2026 | $1.06 | $1.10 | +3.77% | Beat |
| Jan 29, 2026 | $0.84 | $0.89 | +5.95% | Beat |
Earnings history
| Date | EPS · est | EPS · actual | Surprise | Revenue · est | Revenue · actual | Result |
|---|---|---|---|---|---|---|
| No earnings history available. | ||||||
Analyst estimates · annual
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||
Analyst estimates · quarterly
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||